Price (delayed)
$115.15
Market cap
$14.21B
P/E Ratio
94.39
Dividend/share
$0.28
EPS
$1.22
Enterprise value
$17.21B
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.